<?xml-stylesheet type="text/css" href="C:\Users\Fernando\Documents\CIPF\Pharm Pract\Pubmed Central\JATS_OXYGEN\jats.css"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Pharm Pract (Granada)</journal-id><journal-id journal-id-type="iso-abbrev">Pharm Pract (Granada)</journal-id><journal-title-group><journal-title>Pharmacy Practice</journal-title></journal-title-group><issn pub-type="ppub">1885-642X</issn><issn pub-type="epub">1886-3655</issn><publisher><publisher-name>Centro de Investigaciones y Publicaciones Farmaceuticas</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28042351</article-id><article-id pub-id-type="pmc">5184373</article-id><article-id pub-id-type="publisher-id">pharmpract-14-800</article-id><article-id pub-id-type="doi">10.18549/PharmPract.2016.04.800</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Evaluating community pharmacy practice in Qatar using simulated patient method:acute gastroenteritis management </article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ibrahim</surname><given-names>Mohamed I.</given-names></name><aff>Professor of Social and Administrative Pharmacy, College of Pharmacy, <institution>Qatar University</institution>. Doha (<country>Qatar</country>). <email xlink:href="mohamedizham@qu.edu.qa">mohamedizham@qu.edu.qa</email></aff></contrib><contrib contrib-type="author"><name><surname>Palaian</surname><given-names>Subish</given-names></name><aff>Associate Professor of Pharmacy Practice, <institution>Gulf Medical University</institution>. Ajman (<country>United Arab Emirates</country>). <email xlink:href="subishpalaian@gmail.com">subishpalaian@gmail.com</email></aff></contrib><contrib contrib-type="author"><name><surname>Al-Sulaiti</surname><given-names>Fatima</given-names></name><aff>College of Pharmacy, <institution>Qatar University</institution>. Doha (<country>Qatar</country>). <email xlink:href="fa091335@student.qu.edu.qa">fa091335@student.qu.edu.qa</email></aff></contrib><contrib contrib-type="author"><name><surname>El-Shami</surname><given-names>Somia</given-names></name><aff>College of Pharmacy, <institution>Qatar University</institution>. Doha (<country>Qatar</country>). <email xlink:href="se081561@student.qu.edu.qa">se081561@student.qu.edu.qa</email></aff></contrib></contrib-group><pub-date pub-type="ppub" iso-8601-date="20130331"><season>Oct-Dec</season><year iso-8601-date="2012">2016</year></pub-date><pub-date pub-type="epub" iso-8601-date="20130328"><day>15</day><month>12</month><year iso-8601-date="2012">2016</year></pub-date><volume>14</volume><issue>4</issue><elocation-id>800</elocation-id><history><date date-type="received"><day>15</day><month>5</month><year>2016</year></date><date date-type="accepted"><day>22</day><month>11</month><year>2016</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; Pharmacy Practice</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Objective:</title><p>To evaluate Qatari pharmacists&#x02019; prescribing, labeling, dispensing and counseling practices in response to acute community-acquired gastroenteritis.</p></sec><sec id="st2"><title>Methods:</title><p>The simulated patient method was used in this study. Thirty pharmacies in Doha were randomly selected and further randomized into two groups: Face-to-Face (n=15) vs. Telephone-call (n=15) per simulated patient; 2 simulated patients were involved. Prescribing, labeling, dispensing and counseling practices were assessed. Data analysis was performed using Mann-Whitney and chi square tests at alpha=0.05.</p></sec><sec id="st3"><title>Results:</title><p>Most pharmacists prescribed and dispensed medicines (96%), including antimicrobials (43.9%), antidiarrheals (36%), antiemetics (5.1%) and antipyretics (3%). Counseling practices were poor (62.1% in the face-to-face group vs 70% in the telephone-call group did not counsel simulated patients about the dispensed medicines; p-value=0.50). In more than one-third of the encounters, at least one labeling parameter was missing. The duration of each interaction in minutes was not significantly different between the groups [median (IQR); 3(4.25) in the face-to-face group versus 2(0.25) in the telephone-call group; p-value=0.77]. No significant differences in prescribing or dispensing behaviors were present between groups (p-value&#x0003e;0.05).</p></sec><sec id="st4"><title>Conclusion:</title><p>Qatar community pharmacists&#x02019; labeling, dispensing, and counseling practices were below expectation, thus urging the need for continuous professional development.</p></sec></abstract><kwd-group kwd-group-type="MESH"><kwd>Patient Simulation</kwd><kwd>Community Pharmacy Services</kwd><kwd>Pharmacies</kwd><kwd>Professional Practice</kwd><kwd>Gastroenteritis</kwd><kwd>Qatar</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>INTRODUCTION</title><p>As per the World Health Organization (WHO), community pharmacists are the health professionals
who are the easiest for the public to reach and visit. They can either dispense prescription
medications or sell over-the-counter medications.<xref rid="ref1" ref-type="bibr">1</xref> In many
countries, private community pharmacies, as primary care providers, are considered a valuable
resource for health advice and medicines in communities.<xref rid="ref2" ref-type="bibr">2</xref>
Under the recent Qatar National Health Strategy (NHS 2011&#x02013;2016), primary care is a foundation
for healthcare delivery for the country.<xref rid="ref3" ref-type="bibr">3</xref> It also emphasizes
the need for a community pharmacy network that is supported by appropriate policy and process. In
addition, the focus is to decrease the reliance on hospitals for filling drug prescriptions, leading
to increased efficiency and enhanced access. These could lay the foundation for efficient and
accessible healthcare and lead to a strengthened role of community pharmacies in supporting
patients. As per the NHS 2011-16, the target outcomes of the strategy are to increase service
efficiency and effectiveness, ensure the availability of medicines and increase the utilization of
the services by providers.<xref rid="ref3" ref-type="bibr">3</xref> However, the quality of the
service provided by community pharmacies in developing countries has often been questioned and is
often suboptimal.<xref rid="ref4" ref-type="bibr">4</xref>,<xref rid="ref5" ref-type="bibr">5</xref>,<xref rid="ref6" ref-type="bibr">6</xref> Kheir and Michael reviewed the challenges and
opportunities of pharmacy practice in Qatar.<xref rid="ref7" ref-type="bibr">7</xref> They reported
that the community pharmacists still provide traditional services (i.e., product-oriented services
by selling and dispensing medicines). In addition, the community pharmacies are not part of the core
health care delivery system. In a national survey by El Hajj et al, 40% of pharmacists in
Qatar reported being dissatisfied with their professional roles.<xref rid="ref8" ref-type="bibr">8</xref></p><p>Acute gastroenteritis (AGE) is a &#x02018;diarrheal disease of rapid onset, with or without accompanying symptoms and signs, such as nausea, vomiting, fever, or abdominal pain&#x02019;.<xref rid="ref9" ref-type="bibr">9</xref> In developed countries, diarrheal diseases are a significant cause of morbidity across all age groups. A high percentage of patients of all ages are affected by viruses.<xref rid="ref10" ref-type="bibr">10</xref> The clinical effects of acute cases range from symptomatic infection to severe dehydration and death. Viral gastroenteritis normally presents with a short prodrome, with vomiting and mild fever, followed by 1-4 days of non-bloody, watery diarrhea. Viral gastroenteritis is generally a self-limiting watery diarrheal illness with no requirement for antibiotics. In this condition, there is a possibility for irrational dispensing by community pharmacists. Hence, the authors chose to use this condition as the simulated disease in this study.</p><p>There has been a paucity of data regarding the quality of pharmacy services in the middle-east countries, particularly in Qatar. Thus, it would be interesting to study the shortcomings in professional practice in terms of advice-giving and the rational use and supply of medicines. In Qatar, medicines are prescribed by the medical doctors and dispensed by the pharmacists. In community pharmacy setting, pharmacists dispense prescription items, and recommend and sell the non-prescription products e.g. over-the-counter medicines. In addition to consumers&#x02019; visits to the pharmacies, it is quite common for the people especially the local people to order medicines or get their prescriptions filled through telephone calls. For the latter condition, usually the medicines will be pick up by the house driver. Pharmacists are expected to contribute effectively to the health care system and contribute to achieving Qatar Vision 2030, which emphasizes human, social, economic and environmental development<xref rid="ref11" ref-type="bibr">11</xref>, and to QNHS2011-16.<xref rid="ref3" ref-type="bibr">3</xref> To achieve the above goals, the barriers to the provision of higher quality care and ways in which these might be overcome must be identified and examined.</p><p>In this study, the authors aimed to determine the prescribing practices and the information provided, both verbal and written (labeling), by Qatari community pharmacists to acute gastroenteritis patients.</p></sec><sec sec-type="methods" id="sec1-2"><title>METHODS</title><p>The research proposal was approved by the Qatar University Institutional Review Board (QU-IRB: 167/12).</p><sec id="sec2-1"><title>Study design</title><p>In this study, a non-traditional survey method (i.e., the simulated patient method using mystery patient/shopper) was adopted. This method provides a way to document unconscious real behavior and practice from the client&#x02019;s perspective in a first-hand and standardized fashion. This method is also simple and is a method for assessing the community pharmacists&#x02019; dispensing practices.<xref rid="ref12" ref-type="bibr">12</xref>,<xref rid="ref13" ref-type="bibr">13</xref> The simulated patient method, which is also described in literature as the mystery shopper technique, is a method that can be effectively used to study the practice perspectives and professional behaviors. It is a tested and well-accepted method for evaluating community pharmacists&#x02019; professional behaviors.<xref rid="ref14" ref-type="bibr">14</xref></p><p>The simulated patients were final year BSc(Pharm) students from the College of Pharmacy in the Qatar University. They were basically trained to act as patients and pretend to produce a real-life scenario. The simulated patient training included expectations of care, normalizing the AGE experience, introduction and development of scenarios, colloquialisms, researcher-patient balance, dealing with tricky questions/situations, extensive role playing, and data capture tools. Two simulated patients were trained on how to act as an AGE patient and the types of questions to ask via face-to-face interaction/consultation (pharmacy visits) and consultation and request through a telephone call (see <xref ref-type="fig" rid="F1">Figure 1</xref>).</p><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Study flow chart</p></caption><graphic xlink:href="pharmpract-14-800-g001"/></fig></sec><sec id="sec2-2"><title>Study subjects</title><p>Of the 175 pharmacies in Qatar (on the list of pharmacies obtained from the Supreme Council of Health (SCH)), 30 community pharmacies in Doha, the capital city, were randomly selected. These 30 pharmacies were randomized using IBM SPSS Statistics for Windows, Version 21.0 (Armonk, NY: IBM Corp.) into 2 groups using a simple randomization technique: Group 1 (n=15): face-to-face interaction and Group 2 (n=15): telephone call interaction. For each pharmacy, two encounters were done (i.e. 30 visits for face-to-face interactions and 30 interactions through telephone calls, for a total of 60 encounters).</p></sec><sec id="sec2-3"><title>Study tools development and validation</title><p>The following scenarios, questions and dialogue were used by the simulated patients during the data collection process (face-to-face and telephone call) (<xref ref-type="table" rid="T1">Table 1</xref>). The scenario was developed in consultation with a physician and a pharmacist. In addition, the scenario mimicked the common behavior of the consumers in the country and region, e.g., insisting on a medicine if referral advice is provided, and it is typical for patients to insist on an antibiotic; frequently, a patient will not be satisfied when leaving the pharmacy without a single medicine. Furthermore, it is appropriate to assess the pharmacist&#x02019;s profit-making behavior vs professionalism. The pharmacy authority applies strict regulations on the use of antibiotics; thus, it is also interesting for researchers to assess pharmacists&#x02019; behavior.</p><table-wrap orientation="portrait" id="T1" position="float"><label>Table 1</label><caption><p>The simulated client scenario</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="center" rowspan="1" colspan="1">Stage</th><th align="center" rowspan="1" colspan="1">Activity</th></tr></thead><tbody><tr><td align="left" rowspan="4" valign="top" colspan="1">I. Entry into pharmacy and presenting symptoms</td><td align="left" rowspan="1" colspan="1">SC goes into the target pharmacy and greets the pharmacist (get the pharmacist not the staff) and presented the following symptoms:</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x0201c;I am looking for medicines for diarrhea&#x0201d;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x0201c;I had diarrhea for the last 2 days; went to the toilet 3-4 times a day&#x0201d;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x0201c;I vomited twice, have cramping at the abdominal site and slight fever; I am feeling tired with body pain and very uncomfortable&#x0201d;</td></tr><tr><td align="left" colspan="2" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">II. Waiting for the response</td><td align="left" rowspan="1" colspan="1">The SC waits for the response from pharmacist</td></tr><tr><td align="left" colspan="2" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="10" valign="top" colspan="1">III. Receiving advice</td><td align="left" rowspan="1" colspan="1">The SC observe the activities performed by the pharmacist in a sequential manner</td></tr><tr><td align="left" rowspan="1" colspan="1">Any advice (if given)</td></tr><tr><td align="left" rowspan="1" colspan="1">Type of non-pharmacological advice given</td></tr><tr><td align="left" rowspan="1" colspan="1">Details on prescribed medicines</td></tr><tr><td align="left" rowspan="1" colspan="1">What type of medicines? For what purpose? How was the label? Adequate? Quality?</td></tr><tr><td align="left" rowspan="1" colspan="1">If the pharmacists ask the SCs to see a physician, and refuse to treat, it is considered good</td></tr><tr><td align="left" rowspan="1" colspan="1">However, insist to have medicines before seeing a physician.</td></tr><tr><td align="left" rowspan="1" colspan="1">If they prescribe medicines, look for any antibiotic. If none, ask for one.</td></tr><tr><td align="left" rowspan="1" colspan="1">Look for their response.</td></tr><tr><td align="left" rowspan="1" colspan="1">The payment made (in Qatari riyals)</td></tr><tr><td align="left" colspan="2" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">IV. Thanks giving</td><td align="left" rowspan="1" colspan="1">Before leaving, wish thank you.</td></tr><tr><td align="left" colspan="2" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">V. Documentation of the observations in the data collection form</td><td align="left" rowspan="1" colspan="1">After leaving, a distance from the pharmacy, maybe in the car, note down all the information</td></tr></tbody></table></table-wrap><p>A data collection form was used to document all of the information and data. The data collection form consisted of &#x02018;Numbers and categories of medicines dispensed&#x02019;, &#x02018;Cost of medications dispensed&#x02019;, &#x02018;Brand or generic medicines&#x02019;, &#x02018;Labeling standard&#x02019;, &#x02018;Counselling standard&#x02019;, &#x02018;Symptomatic diagnosis scenario&#x02019;, &#x02018;Adherence to therapeutic guidelines&#x02019;, &#x02018;Appropriateness of dosage regimen&#x02019;, and &#x02018;Refusal or agreeable to dispense ABC&#x02019;.</p></sec><sec id="sec2-4"><title>Validation of method</title><p>The researchers pre-tested the data collection method to assess its content validity by showing it to faculty members in the College of Pharmacy and a general practitioner practicing in Qatar. After making improvements to the pilot test [here, the researchers used the method (<xref ref-type="table" rid="T1">Table 1</xref>) on a very small sample size of 3 community pharmacies; these 3 pharmacies were not included in the final study], the method was considered acceptable and was finalized for the main study. The simulated patients were trained 2-3 hours before the pilot study and again after the pilot study. Feedback was obtained from the simulated patients. Problems were rectified, and the necessary improvement/changes were made to the tool and study design.</p></sec><sec id="sec2-5"><title>Outcome measures</title><p>The various outcomes measured in the study were &#x02018;Background of the community pharmacy: name of pharmacy, location, gender of the pharmacist, type of pharmacy&#x02019;, &#x02018;Quality of information and advice provided by the community pharmacists: patient-, disease- and medicine-related&#x02019;, &#x02018;Type and quality of medicines prescribed and dispensed: class of medicines, branded vs generic, number of medicines&#x02019;, and &#x02018;Cost of medicines: amount of money paid by mystery patient &#x02013; each medicine and total amount&#x02019;.</p></sec><sec id="sec2-6"><title>Data collection method</title><p>Information gathered through face-to-face interactions was documented in a pre-tested form (tested during pilot study) immediately after leaving the premise, thus ensuring that the activity was not observed by the concerned pharmacy staff. Similarly, the information gathered through telephone interactions was documented in a pre-tested form immediately after the telephone conversations. The labeling data were gathered after picking up the medicines. Data about counseling, if provided through the telephone conversation, were gathered by the simulated patients or, if the medicines were picked up later, by the simulated patients.</p></sec><sec id="sec2-7"><title>Data management and analysis</title><p>Descriptive statistics, such as the mean (SD), median (IQR), and frequency (%), were used. The normality test was carried out using the Kolmogorov Smirnov test. Student&#x02019;s t-test or the Mann-Whitney test was used for continuous data, and the Chi-square test or Fisher&#x02019;s exact test was used for categorical data at an alpha level of 0.05 to compare between the groups and 2 simulated patients to assess the consistency of practices. The statistical software IBM SPSS Statistics for Windows, Version 21.0 (Armonk, NY: IBM Corp.) was used for data analysis.</p></sec><sec id="sec2-8"><title>Pilot Study</title><p>The study design and tool used were tested with 3 pharmacies before the major study to ensure the feasibility of the study, to identify and rectify any possible problems in the study, to estimate the time used for each method, and to test the data collection form and data analysis procedures.</p></sec></sec><sec sec-type="results" id="sec1-3"><title>RESULTS</title><p>Overall, 30 community pharmacies were visited by 2 simulated patients, for a total of 60 community pharmacy encounters. The demographic details of the respondents are listed in <xref ref-type="table" rid="T2">Table 2</xref>. There were no significant differences in the study sample&#x02019;s demographics (p-value&#x0003e;0.05).</p><table-wrap orientation="portrait" id="T2" position="float"><label>Table 2</label><caption><p>Demographic characteristics of study subjects (n=30)</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="center" rowspan="3" colspan="1">Item</th><th align="center" colspan="2" rowspan="1">Intervention</th><th align="center" rowspan="3" colspan="1">p value<xref ref-type="table-fn" rid="t2f1">*</xref></th></tr><tr><th align="center" colspan="2" rowspan="1"><hr/></th></tr><tr><th align="center" rowspan="1" colspan="1">Visit (n=30)</th><th align="center" rowspan="1" colspan="1">Telephone call (n=30)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Language (n, %)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="3" valign="top" colspan="1">0.070</td></tr><tr><td align="right" rowspan="1" colspan="1">English</td><td align="center" rowspan="1" colspan="1">11 (36.67)</td><td align="center" rowspan="1" colspan="1">18 (60)</td></tr><tr><td align="right" rowspan="1" colspan="1">Arabic</td><td align="center" rowspan="1" colspan="1">19 (63.33)</td><td align="center" rowspan="1" colspan="1">12 (40)</td></tr><tr><td align="center" colspan="4" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Type of Pharmacy (n, %)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="3" valign="top" colspan="1">0.597</td></tr><tr><td align="right" rowspan="1" colspan="1">Chain</td><td align="center" rowspan="1" colspan="1">16 (53.33)</td><td align="center" rowspan="1" colspan="1">16 (53.33)</td></tr><tr><td align="right" rowspan="1" colspan="1">Independent</td><td align="center" rowspan="1" colspan="1">14 (46.66)</td><td align="center" rowspan="1" colspan="1">14 (46.66)</td></tr><tr><td align="center" colspan="4" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Gender of Pharmacist (n, %)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="3" valign="top" colspan="1">0.067</td></tr><tr><td align="right" rowspan="1" colspan="1">Male</td><td align="center" rowspan="1" colspan="1">26 (86.67)</td><td align="center" rowspan="1" colspan="1">20 (66.67)</td></tr><tr><td align="right" rowspan="1" colspan="1">Female</td><td align="center" rowspan="1" colspan="1">4 (13.33)</td><td align="center" rowspan="1" colspan="1">10 (33.3)</td></tr><tr><td align="center" colspan="4" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Ethnicity of Pharmacist (n, %)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="3" valign="top" colspan="1">0.121</td></tr><tr><td align="right" rowspan="1" colspan="1">Arab</td><td align="center" rowspan="1" colspan="1">18 (60)</td><td align="center" rowspan="1" colspan="1">18 (40)</td></tr><tr><td align="right" rowspan="1" colspan="1">Non-Arab</td><td align="center" rowspan="1" colspan="1">12 (40)</td><td align="center" rowspan="1" colspan="1">12 (60)</td></tr></tbody></table><table-wrap-foot><fn id="t2f1"><label>*</label><p>Analysis was carried out using Chi-Square test</p></fn></table-wrap-foot></table-wrap><p>The labeling included dose frequency (73.3% of medicines in the visit group vs. 75.9% in the Telephone-call group; p-value=0.824), dose (66.7% of medicines in the visit group vs. 79.3% in the Telephone-call group; p-value=0.27) and course duration (34.5% of medicines in the visit group vs. 33.3% in the Telephone-call group; p-value=0.92). The details are summarized in <xref ref-type="table" rid="T3">Table 3</xref>.</p><table-wrap orientation="portrait" id="T3" position="float"><label>Table 3</label><caption><p>Labeling quality of the community pharmacies (n=30)</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="center" rowspan="1" colspan="1">Labeling Indicators</th><th align="center" rowspan="1" colspan="1">Visit (n=30) [%]</th><th align="center" rowspan="1" colspan="1">Telephone Call (n=30) [%]</th><th align="center" rowspan="1" colspan="1">p-value <xref ref-type="table-fn" rid="t3f1">*</xref></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Writing medicine name, drug strength, date of dispensing, expiry date and auxiliary labels.</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="3" valign="top" colspan="1">-</td></tr><tr><td align="right" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="right" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">100</td></tr><tr><td align="center" colspan="4" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Dosing frequency</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="3" valign="top" colspan="1">0.824</td></tr><tr><td align="right" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">73.3</td><td align="center" rowspan="1" colspan="1">75.9</td></tr><tr><td align="right" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">26.7</td><td align="center" rowspan="1" colspan="1">24.1</td></tr><tr><td align="center" colspan="4" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Dose</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="3" valign="top" colspan="1">0.275</td></tr><tr><td align="right" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">66.7</td><td align="center" rowspan="1" colspan="1">79.3</td></tr><tr><td align="right" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">33.3</td><td align="center" rowspan="1" colspan="1">20.7</td></tr><tr><td align="center" colspan="4" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Course duration</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="3" valign="top" colspan="1">0.926</td></tr><tr><td align="right" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">34.5</td><td align="center" rowspan="1" colspan="1">33.3</td></tr><tr><td align="right" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">65.5</td><td align="center" rowspan="1" colspan="1">66.7</td></tr></tbody></table><table-wrap-foot><fn id="t3f1"><label>*</label><p>Analysis was carried out using Chi-Square test</p></fn></table-wrap-foot></table-wrap><p>The findings revealed that none of the pharmacists assessed the past medical history of the simulated patients. No significant differences in prescribing and dispensing behavior were present between the groups (p-value&#x0003e;0.05). Details are tabulated in <xref ref-type="table" rid="T4">Table 4</xref>.</p><table-wrap orientation="portrait" id="T4" position="float"><label>Table 4</label><caption><p>Counseling practices across community pharmacists (n=30)</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="center" rowspan="1" colspan="1">Counseling Indicators</th><th align="center" rowspan="1" colspan="1">Visit (n=30) [%]</th><th align="center" rowspan="1" colspan="1">Telephone Call (n=30) [%]</th><th align="center" rowspan="1" colspan="1">p-value <xref ref-type="table-fn" rid="t4f1">*</xref></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Name, indication, dosage and route of administration</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="3" valign="top" colspan="1">0.500</td></tr><tr><td align="right" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">37.9</td><td align="center" rowspan="1" colspan="1">30</td></tr><tr><td align="right" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">62.1</td><td align="center" rowspan="1" colspan="1">70</td></tr><tr><td align="center" colspan="4" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Explaining time for a medication to show an effect</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="3" valign="top" colspan="1">0.321</td></tr><tr><td align="right" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3.3</td></tr><tr><td align="right" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">96.7</td></tr><tr><td align="center" colspan="4" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Explaining how long the patient might be taking the medication regimen</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="3" valign="top" colspan="1">0.143</td></tr><tr><td align="right" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">6.9</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="right" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">93.1</td><td align="center" rowspan="1" colspan="1">100</td></tr><tr><td align="center" colspan="4" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Asking about other allergies and treatments</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="3" valign="top" colspan="1">-</td></tr><tr><td align="right" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="right" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">100</td></tr><tr><td align="center" colspan="4" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Discussing benefits, adverse drug reactions, precautions or contraindications</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="3" valign="top" colspan="1">-</td></tr><tr><td align="right" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="right" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">100</td></tr></tbody></table><table-wrap-foot><fn id="t4f1"><label>*</label><p>Analysis was carried out using Chi-Square test</p></fn></table-wrap-foot></table-wrap><p>The most commonly dispensed drug category was &#x02018;antibacterials (n=41; 43.16%), followed by antidiarrheals (n=36; 37.89%) and others. The details are presented in <xref ref-type="table" rid="T5">Table 5</xref>.</p><table-wrap orientation="portrait" id="T5" position="float"><label>Table 5</label><caption><p>Therapeutic category of dispensed drugs (n=95)</p></caption><table frame="hsides" rules="all" width="100%"><thead><tr><th align="center" rowspan="1" colspan="1">Therapeutic category</th><th align="center" rowspan="1" colspan="1">n</th><th align="center" rowspan="1" colspan="1">%</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Antibacterial</td><td align="center" rowspan="1" colspan="1">41</td><td align="center" rowspan="1" colspan="1">43.16</td></tr><tr><td align="left" rowspan="1" colspan="1">Antidiarrheal</td><td align="center" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1">37.89</td></tr><tr><td align="left" rowspan="1" colspan="1">Antiemetic</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">4.21</td></tr><tr><td align="left" rowspan="1" colspan="1">Antidehydration</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">4.21</td></tr><tr><td align="left" rowspan="1" colspan="1">Adsorbent</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">3.16</td></tr><tr><td align="left" rowspan="1" colspan="1">Analgesic</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2.11</td></tr><tr><td align="left" rowspan="1" colspan="1">Antibacterial/amebicidal combination</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Vitamin</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Antiemetic/pain killer combination</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.05</td></tr><tr><td align="left" rowspan="1" colspan="1">H2 blocker</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Antimuscarinic agent</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.05</td></tr></tbody></table></table-wrap><p>Of the total 95 drugs prescribed, the most common one was loperamide (an antimotility drug), accounting for 37.89% (n=36), followed by nitrofuroxazide (n=21; 22.11%). Details are listed in <xref ref-type="table" rid="T6">Table 6</xref>.</p><table-wrap orientation="portrait" id="T6" position="float"><label>Table 6</label><caption><p>Individual drugs analyzed (n=95)</p></caption><table frame="hsides" rules="all" width="100%"><thead><tr><th align="center" rowspan="1" colspan="1">Individual drugs</th><th align="center" rowspan="1" colspan="1">n</th><th align="center" rowspan="1" colspan="1">%</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Loperamide</td><td align="center" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1">37.89</td></tr><tr><td align="left" rowspan="1" colspan="1">Nitrofuroxazide</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">22.11</td></tr><tr><td align="left" rowspan="1" colspan="1">Metronidazole</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">12.63</td></tr><tr><td align="left" rowspan="1" colspan="1">Diloxanide+metronidazole</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">4.21</td></tr><tr><td align="left" rowspan="1" colspan="1">Oral rehydration salt</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">4.21</td></tr><tr><td align="left" rowspan="1" colspan="1">Domperidone</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">3.16</td></tr><tr><td align="left" rowspan="1" colspan="1">Nitrofuroxide</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2.11</td></tr><tr><td align="left" rowspan="1" colspan="1">Activated charcoal</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2.11</td></tr><tr><td align="left" rowspan="1" colspan="1">Tinidazole</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2.11</td></tr><tr><td align="left" rowspan="1" colspan="1">Furazolidone</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Multivitamins</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Pectin+ light coal</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Metoclopramide</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Metoclopramide + antipyretic agent</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Diclofenac</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Ibuprofen</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Mebaverine</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Ranitidine</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.05</td></tr></tbody></table></table-wrap><p>The median (IQR) time spent by the community pharmacist is listed in <xref ref-type="table" rid="T7">Table 7</xref>. It was observed that the duration of interaction in minutes was not significantly different between the groups [median (IQR); 2(2.0-5.0) in the visit group vs. 2(1.0-4.0) in the Telephone-call group, p-value=0.77]. It was noticed that in up to 75% of the cases, the cost was less than QAR30.00 (USD 8.24; 1 Qatari Riyal =0.27 USD). A higher number (30%) of the prescriptions charged less than QAR10.00 / USD 2.75, followed by QAR20.00-29.99 / USD 5.5-8.24 (28.3%) and 16.7% were from QAR10.00-19.99/USD 2.75-5.49. The cost per prescription ranged from QAR0 to QAR89/USD 0-24.44 (<xref ref-type="table" rid="T7">Table 7</xref>).</p><table-wrap orientation="portrait" id="T7" position="float"><label>Table 7</label><caption><p>Duration of interaction, number and cost of medicines</p></caption><table frame="hsides" rules="all" width="100%"><thead><tr><th align="center" rowspan="2" colspan="1">Item</th><th align="center" colspan="2" rowspan="1">Type of intervention</th><th align="center" rowspan="2" colspan="1">p-value<xref ref-type="table-fn" rid="t7f1">*</xref></th></tr><tr><th align="center" rowspan="1" colspan="1">Visit (n=30)</th><th align="center" rowspan="1" colspan="1">Telephone call (n=30)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Duration of interaction in minutes (Median, IQR)</td><td align="center" rowspan="1" colspan="1">2.0 (2.0-5.0)</td><td align="center" rowspan="1" colspan="1">2.0 (1.0-4.0)</td><td align="center" rowspan="1" colspan="1">0.770</td></tr><tr><td align="left" rowspan="1" colspan="1">Number of medicines (Median, IQR)</td><td align="center" rowspan="1" colspan="1">1 (1-2)</td><td align="center" rowspan="1" colspan="1">1 (1-2)</td><td align="center" rowspan="1" colspan="1">0.831</td></tr><tr><td align="left" rowspan="1" colspan="1">Total cost per prescription in Qatari Riyals<xref ref-type="table-fn" rid="t7f2">**</xref> (Median, IQR)</td><td align="center" rowspan="1" colspan="1">20.00 (7.00-37.00)</td><td align="center" rowspan="1" colspan="1">19.25 (7.00-28.50)</td><td align="center" rowspan="1" colspan="1">0.536</td></tr></tbody></table><table-wrap-foot><fn><p>Note:</p></fn><fn id="t7f1"><label>*</label><p>Analysis was carried out using Mann-Whitney test.</p></fn><fn id="t7f2"><label>**</label><p>1 Qatari Riyal =USD 0.27</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion" id="sec1-4"><title>DISCUSSION</title><p>Community pharmacy practice is an important role of the pharmacist and an integral part of the healthcare system.<xref rid="ref12" ref-type="bibr">12</xref>,<xref rid="ref15" ref-type="bibr">15</xref> Among the Gulf countries in the Middle East, the community pharmacy practice is undergoing changes, and pharmacists are expected to perform patient care and related activities with a public health focus.<xref rid="ref16" ref-type="bibr">16</xref>,<xref rid="ref17" ref-type="bibr">17</xref> It is also noted that generally, the public relies on community pharmacists.<xref rid="ref18" ref-type="bibr">18</xref> The main reason for general public reliance is the ease of access, the absence of consultation charges and the simple over-the-counter medicines to solve problems for minor ailments that are often self-limiting. This study, however, found a poor community pharmacy practice in terms of dispensing, labeling and counseling.</p><p>At times, it can be important to promote self-medication, but only for minor ailments. There has been an argument about responsible self-medication.<xref rid="ref19" ref-type="bibr">19</xref>,<xref rid="ref20" ref-type="bibr">20</xref> According to the WHO, &#x02018;it is the practice whereby individuals treat their ailments and conditions with medicines which are approved and available without prescription, and which are safe and effective when used as directed&#x02019;.<xref rid="ref19" ref-type="bibr">19</xref> According to the WHO, responsible self-medication and medicines with proven safety, quality and efficacy should be used. The medicines that should be used are those specified for disorders that are self-recognizable and for some chronic or recurrent conditions (following an initial medical diagnosis).<xref rid="ref19" ref-type="bibr">19</xref> However, if used without care, self-medication can be a huge threat to the healthcare system and can lead to adverse drug reactions, with one of the most common being self-medication with analgesics, which can lead to kidney toxicity.</p><p>In Qatar, the patients seem to have known about the role of community pharmacists in self-medication and were willing to use their services.<xref rid="ref21" ref-type="bibr">21</xref> It is interesting to note that none of the community pharmacists in Qatar are Qataris or graduates produced by the Qatar University College of Pharmacy. They are expatriates with different backgrounds and knowledge and skill levels and are mainly from developing countries, where pharmacy practices is not well established. Thus, there is a need for scrutiny and the continued evaluation of practicing pharmacists, although there is a one-time registration requirement for expatriate pharmacists to practice in Qatar.</p><p>Because the simulated patient method provides actual responses by a respondent and considers behavioral aspects and real-life scenarios, we chose this method. This methodology has also been used by other researchers and has been documented in the literature.<xref rid="ref22" ref-type="bibr">22</xref>,<xref rid="ref23" ref-type="bibr">23</xref> Puspitasari et al evaluated the published research in 1993-2007 and reported that among all of the research methods, simulated-patient was a more reliable method for evaluating counseling practice in pharmacies.<xref rid="ref24" ref-type="bibr">24</xref> In addition to these advantages, this method has numerous other advantages, such as the ability to evaluate actual practice without observation bias, the possibility of having standardized cases for easy comparison, and adaptability to a range of study questions, settings, and sizes.<xref rid="ref25" ref-type="bibr">25</xref></p><p>The finding of our study reveals poor dispensing practices (e.g., inappropriate medicines,
improper labeling) among community pharmacists. A similar study, in Malaysia, used the simulated
patient method to show a poor dispensing practice and adherence to guidelines by the community
pharmacists.<xref rid="ref26" ref-type="bibr">26</xref> One study from India applied simulated
patient method (pediatric diarrhea) and assessed the dispensing practices of private pharmacies. The
authors found that pharmacists used prescription drugs indiscriminately while refraining from
essential medicine such as oral rehydration salts.<xref rid="ref12" ref-type="bibr">12</xref>
Another simulated patient study from Nigeria documented that only 15% of the community
pharmacists managed acute diarrhea in pediatrics, as per the WHO guidelines.<xref rid="ref27" ref-type="bibr">27</xref> In general, the scenario of community pharmacies in the developing world
reflects poor professional practice and ethical standards.<xref rid="ref28" ref-type="bibr">28</xref>,<xref rid="ref29" ref-type="bibr">29</xref>,<xref rid="ref30" ref-type="bibr">30</xref></p><p>Labeling the dispensed medicines is an important responsibility of pharmacists and is often the first source of drug information for the patients. In our study, not even a single community pharmacist mentioned the name, drug strength, date of dispensing, expiration date or auxiliary labels during the dispensing process. Similarly, the duration for which the medicine should be used was mentioned only in one third of the cases. It is important for community pharmacists to do the labeling. Improper labeling can also be a cause of medication errors and can lead to the incorrect medication, dose or timing. The Institute for Safe Medication Practices standards (ISMP), a US-based nonprofit organization aiming to educate the healthcare community and consumers about safe medicine practices, also provides guidelines for designing labels for the dispensed medications in a community pharmacy.<xref rid="ref31" ref-type="bibr">31</xref> One study from Saudi Arabia reported a good adherence level of labeling guidelines in Riyadh hospitals as per the ISMP.<xref rid="ref32" ref-type="bibr">32</xref></p><p>Patient counseling is an important responsibility of community pharmacists that occurs prior to dispensing medications. According to the American Society of Health-System Pharmacists (ASHP) guidelines, the pharmacist should provide comprehensive information on both the medications and health condition to the patients.<xref rid="ref33" ref-type="bibr">33</xref> Conversely, our research found poor counseling practices by the community pharmacists. It was observed that only one-third of the pharmacists emphasized the name, indication, dosage and route of administration. Poor patient counseling can definitely contribute to non-compliance and therapy failure. While counseling, it is important to note the possible side effects, methods for prevention and early diagnosis. However, in our study, the simulated patients received no information on side effects or allergies.</p><p>According to Barr <italic>et al</italic>.<xref rid="ref34" ref-type="bibr">34</xref>, the treatment of AGE in adults should focus on preventing and treating dehydration. Oral rehydration therapy is the chosen treatment for dehydration. In patients with bloody diarrhea, antimotility agents should not be given, but in patients with watery diarrhea, loperamide/simethicone may improve their symptoms. Probiotic use is preferred to shorten the duration of illnesses. Antibiotics are not recommended for adults with acute diarrhea of unknown pathology. Our findings noted the exorbitant use of the antimotility drug loperamide. Loperamide is an antimotility drug that is used in cases of acute diarrhea, and it carries significant side-effects. Additionally, upon long-term use, it can lead to dependence. Moreover, in the case of diarrhea with an infectious origin (e.g., dysentery with blood and (or) mucus), there is a possibility that the infecting organism to be retained in the gastrointestinal tract and could lead to systemic infections. We also found a high use of antibiotics. The use of antibiotics in acute gastroenteritis with viral diarrhea (as in most cases of diarrhea) is thus highly irrational. Our findings on the inappropriate dispensing of antibiotics of community pharmacists is in agreement with other findings; one study from Egypt found the improper dispensing of antibiotics by community pharmacists<xref rid="ref35" ref-type="bibr">35</xref>, and similar findings were reported in Lebanon<xref rid="ref36" ref-type="bibr">36</xref>, the Ivory coast<xref rid="ref37" ref-type="bibr">37</xref> and many other countries around the world.</p><p>The time spent by the community pharmacist with patients is very important because the effectiveness of counseling improves with adequate time spent and because reinforcement and feedback require time. Time can be a potential barrier to patient counseling.<xref rid="ref38" ref-type="bibr">38</xref> In our study, the community pharmacists took approximately 2-3 minutes to provide counseling, which is very short, in our opinion. It has been documented in the literature that the time taken by the pharmacists during correct counseling is much longer than this.<xref rid="ref39" ref-type="bibr">39</xref></p><sec id="sec2-9"><title>Strengths and limitations of the study</title><p>In general, the simulated patient method is easy and effective for studying behavior and real practices; it reduces observation bias. In middle-eastern pharmacy settings, few studies have used this method. In this study, each pharmacy was visited and tested twice by the simulated patients, and this step could confirm and validate the behavior and practices of pharmacists.</p><p>The sample size is small, and Qatar is a small country; therefore, the findings might not be able to be generalized to other countries. We did not determine whether the simulated patients visited and interacted with the same pharmacist, but we attempted to reduce this potential bias by requesting that the simulated patients visit the pharmacy at the same time of day, e.g., morning or afternoon. In addition, the results may have reflected a specific scenario because the simulated patients insisted on a particular medication. Thus, it may be difficult to extrapolate the findings to the entire pharmacy practice of community pharmacists in Qatar.</p></sec><sec id="sec2-10"><title>Implication for practice</title><p>The findings of the study recommend the need for a minimum standard of practice (policy and practice) and mandatory continuing education programs for community pharmacists. More research is also needed in this area to obtain more in-depth information on the dispensing practices of community pharmacists.</p></sec></sec><sec sec-type="conclusions" id="sec1-5"><title>CONCLUSIONS</title><p>This study explored the regular dispensing practice of community pharmacists in Qatar. The findings revealed a suboptimal dispensing practice that involved less time spent with the patients and the overuse of antidiarrheals and antimicrobials. The patients were also provided with limited information on the usage of medications and their safe use. The overall practice was below expectation.</p></sec></body><back><ack><title>ACKNOWLEDGEMENTS</title><p>The authors acknowledge the community pharmacists who provided their response for the research.</p></ack><fn-group><fn fn-type="COI-statement"><p><bold>CONFLICT OF INTEREST</bold></p><p>The authors declare that there are no conflicts of interests.</p></fn><fn fn-type="supported-by"><p>Funding: This research has been funded by Qatar University student research grant (Grant No.: QUST-CPHFALL-12/13-2</p></fn></fn-group><ref-list><title>References</title><ref id="ref1"><label>1</label><element-citation publication-type="web"><collab>WHO</collab><source>The role of the pharmacist in the health care system. Report of a WHO Consultative Group New Delhi, India, 13-16 December 1988. World Health Organization</source><year>1994</year><date-in-citation>accessed 29 March 2016</date-in-citation><comment>Available at: <uri xlink:href="http://apps.who.int/medicinedocs/pdf/h2995e/h2995e.pdf">http://apps.who.int/medicinedocs/pdf/h2995e/h2995e.pdf</uri></comment></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lalibert&#x000e9;MC</surname><given-names>Perreault S</given-names></name><name><surname>Damestoy</surname><given-names>N</given-names></name><name><surname>Lalonde</surname><given-names>L</given-names></name></person-group><article-title>Ideal and actual involvement of community pharmacists in health promotion and
prevention: a cross-sectional study in Quebec, Canada</article-title><source>BMC Public Health</source><year>2012</year><volume>12</volume><elocation-id>192</elocation-id><comment>doi:10.1186/1471-2458-12-192</comment><pub-id pub-id-type="pmid">22420693</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="web"><collab>National Health Strategy</collab><source>2014 General Secretariat, Supreme Council of Health</source><year>2011-2016</year><date-in-citation>accessed 29 March 2016</date-in-citation><comment>Available at <uri xlink:href="http://www.nhsq.info/app/media/1541">http://www.nhsq.info/app/media/1541</uri></comment></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nga do</surname><given-names>TT</given-names></name><name><surname>Chuc</surname><given-names>NT</given-names></name><name><surname>Hoa</surname><given-names>NP</given-names></name><name><surname>Hoa</surname><given-names>NQ</given-names></name><name><surname>Nguyen</surname><given-names>NT</given-names></name><name><surname>Loan</surname><given-names>HT</given-names></name><name><surname>Toan</surname><given-names>TK</given-names></name><name><surname>Phuc</surname><given-names>HD</given-names></name><name><surname>Horby</surname><given-names>P</given-names></name><name><surname>Van Yen</surname><given-names>N</given-names></name><name><surname>Van Kinh</surname><given-names>N</given-names></name><name><surname>Wertheim</surname><given-names>HF</given-names></name></person-group><article-title>Antibiotic sales in rural and urban pharmacies in northern Vietnam: an observational
study</article-title><source>BMC Pharmacol Toxicol</source><year>2014</year><volume>15</volume><elocation-id>6</elocation-id><comment>doi:10.1186/2050-6511-15-6</comment><pub-id pub-id-type="pmid">24555709</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotwani</surname><given-names>A</given-names></name><name><surname>Wattal</surname><given-names>C</given-names></name><name><surname>Joshi</surname><given-names>PC</given-names></name><name><surname>Holloway</surname><given-names>K</given-names></name></person-group><article-title>Irrational use of antibiotics and role of the pharmacist: an insight from a qualitative study in New Delhi, India</article-title><source>J Clin Pharm Ther</source><year>2012</year><volume>37</volume><issue>3</issue><fpage>308</fpage><lpage>312</lpage><comment>doi:10.1111/j.1365-2710.2011.01293.x</comment><pub-id pub-id-type="pmid">21883328</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gastelurrutia</surname><given-names>MA</given-names></name><name><surname>Larra&#x000f1;aga</surname><given-names>B</given-names></name><name><surname>Garay</surname><given-names>A</given-names></name><name><surname>Echeveste Fde</surname><given-names>A</given-names></name><name><surname>Fernandez-Llimos</surname><given-names>F</given-names></name></person-group><article-title>Impact of a program to reduce the dispensing of antibiotics without a prescription in Spain</article-title><source>Pharm Pract (Granada)</source><year>2013</year><volume>11</volume><issue>4</issue><fpage>185</fpage><lpage>190</lpage><pub-id pub-id-type="pmid">24367457</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kheir</surname><given-names>N</given-names></name><name><surname>Fahey</surname><given-names>M</given-names></name></person-group><article-title>Pharmacy practice in Qatar: challenges and opportunities</article-title><source>South Med Rev</source><year>2011</year><volume>4</volume><issue>2</issue><fpage>92</fpage><lpage>96</lpage><comment>doi:10.5655/smr.v4i2.1007</comment><pub-id pub-id-type="pmid">23093888</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Hajj</surname><given-names>MS</given-names></name><name><surname>Salem</surname><given-names>S</given-names></name><name><surname>Mansoor</surname><given-names>H</given-names></name></person-group><article-title>Public&#x02019;s attitudes towards community pharmacy in Qatar: a pilot study</article-title><source>Patient Prefer Adherence</source><year>2011</year><volume>5</volume><fpage>405</fpage><lpage>422</lpage><comment>doi:10.2147/PPA.S22117</comment><pub-id pub-id-type="pmid">21949604</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="web"><collab>Viral gastroenteritis</collab><source>Medline Plus. US National Library of Medicine</source><date-in-citation>accessed 28 October 2015</date-in-citation><comment>Available at: <uri xlink:href="https://www.nlm.nih.gov/medlineplus/ency/article/000252.htm">https://www.nlm.nih.gov/medlineplus/ency/article/000252.htm</uri></comment></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Tablang</surname><given-names>MVF</given-names></name><name><surname>Wu</surname><given-names>GY</given-names></name></person-group><source>Viral gasteroenteritis</source><date-in-citation>accessed 28 October 2015</date-in-citation><comment>Available at: <uri xlink:href="http://emedicine.medscape.com/article/176515-overview">http://emedicine.medscape.com/article/176515-overview</uri></comment></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="web"><collab>Qatar National Vision</collab><date-in-citation>accessed 28 March 2016</date-in-citation><comment><uri xlink:href="http://www.qu.edu.qa/pharmacy/components/upcoming_events_material/Qatar_National_Vision_2030.pdf">http://www.qu.edu.qa/pharmacy/components/upcoming_events_material/Qatar_National_Vision_2030.pdf</uri></comment></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diwan</surname><given-names>V</given-names></name><name><surname>Sabde</surname><given-names>YD</given-names></name><name><surname>Bystr&#x000f6;m</surname><given-names>E</given-names></name><name><surname>De Costa</surname><given-names>A</given-names></name></person-group><article-title>Treatment of pediatric diarrhea: a simulated client study at private pharmacies of Ujjain, Madhya Pradesh, India</article-title><source>J Infect Dev Ctries</source><year>2015</year><volume>9</volume><issue>5</issue><fpage>505</fpage><lpage>511</lpage><comment>doi:10.3855/jidc.5694</comment><pub-id pub-id-type="pmid">25989170</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Rocha</surname><given-names>CE</given-names></name><name><surname>Bispo</surname><given-names>ML</given-names></name><name><surname>dos Santos</surname><given-names>AC</given-names></name><name><surname>Mesquita</surname><given-names>AR</given-names></name><name><surname>Brito</surname><given-names>GC</given-names></name><name><surname>de Lyra</surname><given-names>DP</given-names><suffix>Jr</suffix></name></person-group><article-title>Assessment of community pharmacists&#x02019; counseling practices with simulated patients who have minor illness: a pilot study</article-title><source>Simul Healthc</source><year>2015</year><volume>10</volume><issue>4</issue><fpage>227</fpage><lpage>238</lpage><comment>doi:10.1097/SIH.0000000000000100</comment><pub-id pub-id-type="pmid">26222504</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>MC</given-names></name><name><surname>Skelton</surname><given-names>JR</given-names></name><name><surname>Bond</surname><given-names>CM</given-names></name><name><surname>Croft</surname><given-names>P</given-names></name><name><surname>Wiskin</surname><given-names>CM</given-names></name><name><surname>Grimshaw</surname><given-names>JM</given-names></name><name><surname>Mollison</surname><given-names>J</given-names></name></person-group><article-title>Simulated patients in the community pharmacy setting. Using simulated patients to measure practice in the community pharmacy setting</article-title><source>Pharm World Sci</source><year>2004</year><volume>26</volume><issue>1</issue><fpage>32</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">15018257</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teinil&#x000e4;</surname><given-names>T</given-names></name><name><surname>Halmepuro-Jaatinen</surname><given-names>S</given-names></name><name><surname>Yritys</surname><given-names>K</given-names></name><name><surname>Manni</surname><given-names>K</given-names></name><name><surname>Airaksinen</surname><given-names>M</given-names></name></person-group><article-title>Adapting the US Institute for Safe Medication Practices&#x02019; medication safety self-assessment tool for community pharmacies in Finland</article-title><source>Int J Pharm Pract</source><year>2012</year><volume>20</volume><issue>1</issue><fpage>15</fpage><lpage>24</lpage><comment>doi:10.1111/j.2042-7174.2011.00158.x</comment><pub-id pub-id-type="pmid">22236176</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dameh</surname><given-names>M</given-names></name></person-group><article-title>Pharmacy in the United Arab Emirates</article-title><source>South Med Rev</source><year>2009</year><volume>2</volume><issue>1</issue><fpage>15</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">23093873</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kheir</surname><given-names>N</given-names></name><name><surname>Zaidan</surname><given-names>M</given-names></name><name><surname>Younes</surname><given-names>H</given-names></name><name><surname>El Hajj</surname><given-names>M</given-names></name><name><surname>Wilbur</surname><given-names>K</given-names></name><name><surname>Jewesson</surname><given-names>PJ</given-names></name></person-group><article-title>Pharmacy education and practice in 13 middle eastern countries</article-title><source>Am J Pharm Educ</source><year>2008</year><volume>72</volume><issue>6</issue><elocation-id>133</elocation-id><pub-id pub-id-type="pmid">19325953</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basheti</surname><given-names>IA</given-names></name><name><surname>Qunaibi</surname><given-names>EA</given-names></name><name><surname>Hamadi</surname><given-names>SA</given-names></name><name><surname>Abu-Gharbieh</surname><given-names>E</given-names></name><name><surname>Saleh</surname><given-names>S</given-names></name><name><surname>AbuRuz</surname><given-names>S</given-names></name><name><surname>Mohamoud</surname><given-names>M</given-names></name><name><surname>Bulatova</surname><given-names>NR</given-names></name></person-group><article-title>Patient perspectives of the role of the community pharmacist in the Middle East. Jordan, United Arab Emirates and Iraq</article-title><source>Pharmacol Pharm</source><year>2014</year><volume>5</volume><fpage>588</fpage><lpage>599</lpage><comment>doi:10.4236/pp2014.56069</comment></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="book"><collab>WHO</collab><source>The role of the pharmacist in self-care and self-medication, 1998 report of the 4th WHO consultative group on the role of the pharmacist</source><year>1998</year><publisher-loc>The Hague</publisher-loc><publisher-name>WHO</publisher-name></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dayani</surname><given-names>G</given-names></name><name><surname>de Mattos</surname><given-names>GL</given-names></name><name><surname>Modolon</surname><given-names>AG</given-names></name><name><surname>Cristina</surname><given-names>TS</given-names></name></person-group><article-title>Responsible self-medication: review of the process of pharmaceutical attendance</article-title><source>Braz J Pharm Sci</source><year>2004</year><volume>45</volume><issue>4</issue><fpage>625</fpage><lpage>633</lpage><comment>doi:10.1590/S1984-82502009000400004</comment></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilbur</surname><given-names>K</given-names></name><name><surname>Salam</surname><given-names>SE</given-names></name><name><surname>Mohammadi</surname><given-names>E</given-names></name></person-group><article-title>Patient perceptions of pharmacist roles in guiding self-medication of over-the-counter therapy in Qatar</article-title><source>Patient Prefer Adherence</source><year>2010</year><volume>4</volume><fpage>87</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">20517469</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huntington</surname><given-names>D</given-names></name><name><surname>Schuler</surname><given-names>SR</given-names></name></person-group><article-title>The simulated client method: evaluating client-provider interactions in family planning clinics</article-title><source>Stud Fam Plann</source><year>1993</year><volume>24</volume><issue>3</issue><fpage>187</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">8351699</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="web"><collab>How to study medicines use in communities</collab><source>World Health Organization 2004, WHO/EDM/PAR/2004.2</source><date-in-citation>accessed 28 October 2015</date-in-citation><comment>Available at: <uri xlink:href="http://whqlibdoc.who.int/hq/2004/WHO_EDM_PAR_2004.2.pdf">http://whqlibdoc.who.int/hq/2004/WHO_EDM_PAR_2004.2.pdf</uri></comment></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puspitasari</surname><given-names>HP</given-names></name><name><surname>Aslani</surname><given-names>P</given-names></name><name><surname>Krass</surname><given-names>I</given-names></name></person-group><article-title>A review of counseling practices on prescription medicines in community pharmacies</article-title><source>Res Social Adm Pharm</source><year>2009</year><volume>5</volume><issue>3</issue><fpage>197</fpage><lpage>210</lpage><comment>doi:10.1016/j.sapharm.2008.08.006</comment><pub-id pub-id-type="pmid">19733821</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Madden</surname><given-names>JM</given-names></name><name><surname>Quick</surname><given-names>JD</given-names></name><name><surname>Ross-Degnan</surname><given-names>D</given-names></name><name><surname>Kafle</surname><given-names>KK</given-names></name></person-group><article-title>Undercover Careseekers: simulated clients in the study of health provider behavior in developing countries</article-title><source>International Conferences on Improving Use of medicines</source><date-in-citation>accessed 18 March 2016</date-in-citation><comment>Available at: <uri xlink:href="http://archives.who.int/icium/icium1997/posters/1b4_text.html">http://archives.who.int/icium/icium1997/posters/1b4_text.html</uri></comment></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alabid</surname><given-names>AH</given-names></name><name><surname>Ibrahim</surname><given-names>MI</given-names></name><name><surname>Hassali</surname><given-names>MA</given-names></name></person-group><article-title>Antibiotics dispensing for URTIs by community pharmacists (CPs) and general medical practitioners in Penang, Malaysia: A comparative study using simulated patients (SPs)</article-title><source>J Clin Diagn Res</source><year>2014</year><volume>8</volume><issue>1</issue><fpage>119</fpage><lpage>123</lpage><comment>doi:10.7860/JCDR/2014/6199.3923</comment></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogbo</surname><given-names>PU</given-names></name><name><surname>Aina</surname><given-names>BA</given-names></name><name><surname>Aderemi-Williams</surname><given-names>R</given-names></name></person-group><article-title>Management of acute diarrhea in children by community pharmacists in Lagos,
Nigeria</article-title><source>Pharm Pract (Granada)</source><year>2014</year><volume>12</volume><issue>1</issue><elocation-id>376</elocation-id><pub-id pub-id-type="pmid">24644521</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brata</surname><given-names>C</given-names></name><name><surname>Gudka</surname><given-names>S</given-names></name><name><surname>Schneider</surname><given-names>CR</given-names></name><name><surname>Clifford</surname><given-names>RM</given-names></name></person-group><article-title>A review of the provision of appropriate advice by pharmacy staff for self-medication in developing countries</article-title><source>Res Social Adm Pharm</source><year>2015</year><volume>11</volume><issue>2</issue><fpage>136</fpage><lpage>153</lpage><comment>doi:10.1016/j.sapharm.2014.07.003</comment><pub-id pub-id-type="pmid">25139059</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>F</given-names></name></person-group><article-title>Private local pharmacies in low- and middle-income countries: a review of interventions to enhance their role in public health</article-title><source>Trop Med Int Health</source><year>2009</year><volume>14</volume><issue>3</issue><fpage>362</fpage><lpage>372</lpage><comment>doi:10.1111/j.1365-3156.2009.02232.x</comment><pub-id pub-id-type="pmid">19207171</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>F</given-names></name></person-group><article-title>The quality of private pharmacy services in low and middle-income countries: a systematic review</article-title><source>Pharm World Sci</source><year>2009</year><volume>31</volume><issue>3</issue><fpage>351</fpage><lpage>361</lpage><comment>doi:10.1007/s11096-009-9294-z</comment><pub-id pub-id-type="pmid">19343530</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="web"><collab>Institute for Safe Medication Practices</collab><source>Principles of designing a medication label for community and mail order pharmacy prescription packages</source><date-in-citation>accessed 29 March 2016</date-in-citation><comment>Available at: <uri xlink:href="http://www.ismp.org/tools/guidelines/labelFormats/comments/printerVersion.pdf">http://www.ismp.org/tools/guidelines/labelFormats/comments/printerVersion.pdf</uri></comment></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alkhani</surname><given-names>S</given-names></name><name><surname>Ahmed</surname><given-names>Y</given-names></name><name><surname>Bin-Sabbar</surname><given-names>N</given-names></name><name><surname>Almogirah</surname><given-names>H</given-names></name><name><surname>Alturki</surname><given-names>A</given-names></name><name><surname>Albanyan</surname><given-names>H</given-names></name><name><surname>Adam</surname><given-names>M</given-names></name><name><surname>Saleem</surname><given-names>F</given-names></name><name><surname>Aljadhey</surname><given-names>H</given-names></name><name><surname>Hassali</surname><given-names>MA</given-names></name><name><surname>Vaida</surname><given-names>AJ</given-names></name></person-group><article-title>Current practices for labeling medications in hospitals in Riyadh, Saudi Arabia</article-title><source>Saudi Pharm J</source><year>2013</year><volume>21</volume><issue>4</issue><fpage>345</fpage><lpage>349</lpage><comment>doi:10.1016/j.jsps.2012.12.002</comment><pub-id pub-id-type="pmid">24227953</pub-id></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><collab>American Society of Health-System Pharmacists</collab><article-title>ASHP guidelines on pharmacist-conducted patient education and counseling</article-title><source>Am J Health Syst Pharm</source><year>1997</year><volume>54</volume><issue>4</issue><fpage>431</fpage><lpage>434</lpage><pub-id pub-id-type="pmid">9043568</pub-id></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barr</surname><given-names>W</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name></person-group><article-title>Acute diarrhea in adults</article-title><source>Am Fam Physician</source><year>2014</year><volume>89</volume><issue>3</issue><fpage>180</fpage><lpage>189</lpage><pub-id pub-id-type="pmid">24506120</pub-id></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabry</surname><given-names>NA</given-names></name><name><surname>Farid</surname><given-names>SF</given-names></name><name><surname>Dawoud</surname><given-names>DM</given-names></name></person-group><article-title>Antibiotic dispensing in Egyptian community pharmacies: an observational study</article-title><source>Res Social Adm Pharm</source><year>2014</year><volume>10</volume><issue>1</issue><fpage>168</fpage><lpage>184</lpage><comment>doi:10.1016/j.sapharm.2013.03.004</comment><pub-id pub-id-type="pmid">23665078</pub-id></element-citation></ref><ref id="ref36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farah</surname><given-names>R</given-names></name><name><surname>Lahoud</surname><given-names>N</given-names></name><name><surname>Salameh</surname><given-names>P</given-names></name><name><surname>Saleh</surname><given-names>N</given-names></name></person-group><article-title>Antibiotic dispensation by Lebanese pharmacists: a comparison of higher and lower socio-economic levels</article-title><source>J Infect Public Health</source><year>2015</year><volume>8</volume><issue>1</issue><fpage>37</fpage><lpage>46</lpage><comment>doi:10.1016/j.jiph.2014.07.003</comment><pub-id pub-id-type="pmid">25139454</pub-id></element-citation></ref><ref id="ref37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hounsa</surname><given-names>A</given-names></name><name><surname>De Mol</surname><given-names>P</given-names></name></person-group><article-title>Antibiotics dispensed upon the recommendation of staff in private dispensaries in Abidjan in the Ivory Coast</article-title><source>J Pharm Belg</source><year>2009</year><volume>3</volume><fpage>99</fpage><lpage>104</lpage></element-citation></ref><ref id="ref38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albekairy</surname><given-names>AM</given-names></name></person-group><article-title>Pharmacists&#x02019; perceived barriers to patient counseling</article-title><source>J Appl Pharm Sci</source><year>2014</year><volume>4</volume><issue>1</issue><fpage>70</fpage><lpage>73</lpage><comment>doi:10.7324/JAPS.2014.40112</comment></element-citation></ref><ref id="ref39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>Y</given-names></name><name><surname>McCombs</surname><given-names>JS</given-names></name><name><surname>Cheng</surname><given-names>RA</given-names></name><name><surname>Johnson</surname><given-names>KA</given-names></name></person-group><article-title>Pharmacist time requirements for counseling in an outpatient pharmacy</article-title><source>Am J Health Syst Pharm</source><year>2002</year><volume>59</volume><issue>23</issue><fpage>2346</fpage><lpage>2355</lpage><pub-id pub-id-type="pmid">12489376</pub-id></element-citation></ref></ref-list></back></article>